6,7-dimethoxy-3-[(4-methoxyphenyl)methyl]-2-[[(2R)-oxiran-2-yl]methylsulfanyl]quinazolin-4-imine
C21H23N3O4S — CID 1482686
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6,7-dimethoxy-3-[(4-methoxyphenyl)methyl]-2-[[(2R)-oxiran-2-yl]methylsulfanyl]quinazolin-4-imine
6,7-dimethoxy-3-[(4-methoxyphenyl)methyl]-2-[[(2R)-oxiran-2-yl]methylsulfanyl]quinazolin-4-imine (PubChem CID 1482686) has the molecular formula C21H23N3O4S and a molecular weight of 413.50 g/mol. Its IUPAC name is 6,7-dimethoxy-3-[(4-methoxyphenyl)methyl]-2-[[(2R)-oxiran-2-yl]methylsulfanyl]quinazolin-4-imine.
Molecular Properties
| Compound Name | 6,7-dimethoxy-3-[(4-methoxyphenyl)methyl]-2-[[(2R)-oxiran-2-yl]methylsulfanyl]quinazolin-4-imine |
|---|---|
| PubChem CID | 1482686 |
| Molecular Formula | C21H23N3O4S |
| Molecular Weight | 413.50 g/mol |
| Exact Mass | 413.14 |
| IUPAC Name | 6,7-dimethoxy-3-[(4-methoxyphenyl)methyl]-2-[[(2R)-oxiran-2-yl]methylsulfanyl]quinazolin-4-imine |
| SMILES | [H]/N=c1/c2cc(OC)c(OC)cc2nc(SC[C@H]2CO2)n1Cc1ccc(OC)cc1 |
| InChI | InChI=1S/C21H23N3O4S/c1-25-14-6-4-13(5-7-14)10-24-20(22)16-8-18(26-2)19(27-3)9-17(16)23-21(24)29-12-15-11-28-15/h4-9,15,22H,10-12H2,1-3H3/b22-20-/t15-/m1/s1 |
| InChIKey | MNIGGLRMRSFAHO-BQHWHHKNSA-N |
| XLogP | 3.08 |
| TPSA | 81.89 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 413.50 |
| LogP ≤ 5 | 3.08 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 1482686 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.